Develop policies and procedures on how to properly review nanotechnology submissions and handle industry inquiries. This project was recommended by the Office of the Commissioner in response to an anticipated increase in the number of nanotechnology based products that CVM regulates.CVM developed Nanotechnology Policies and Procedures (P&P) in order to strengthen product evaluation capabilities, and ensure a scientifically valid, predictable, and effective process for the review of novel technologies. The Nanotechnology Policies and Procedures include a consistent methodology for regulating nano-scale products. CVM also developed a mechanism to track products that utilize this new technology. CVM anticipates an increase in the number of new animal drugs employing nanotechnology. Properly addressing critical safety and effectiveness questions pertinent to this technology ensure public and animal health protection.1. Prepare an initial draft of Nanotechnology P&P2/28/2010Completed2/17/20102. Create method for tracking nano-scale products3/31/2010Completed3/17/20103. Finalize Nanotechnology P&P for ONADE comment6/30/2010Completed4/26/20104. Implement Nanotechnology P&P in ONADE8/31/2010Completed8/24/2010ONADEOffice of New Animal Drug Evaluationhttp://www.fda.gov/AboutFDA/Transparency/track/ucm203425.htmFDA-TRACK CVM Dashboard਍††਍਍਍਍਍਍਍